Home/Filings/4/0001628280-24-001718
4//SEC Filing

FEBBO WILLIAM J 4

Accession 0001628280-24-001718

CIK 0001448431other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 5:56 PM ET

Size

8.9 KB

Accession

0001628280-24-001718

Insider Transaction Report

Form 4
Period: 2024-01-09
FEBBO WILLIAM J
DirectorCEO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-01-09+9,628481,028 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-01-099,6280 total
    Common Stock (9,628 underlying)
  • Tax Payment

    Common Stock

    2024-01-09$13.25/sh2,884$38,213478,144 total
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
  • [F3]On January 7, 2021, the reporting person was granted 28,883 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0001413987

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 5:56 PM ET
Size
8.9 KB